Filing Details
- Accession Number:
- 0001225208-14-007301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-04 16:44:57
- Reporting Period:
- 2014-02-28
- Filing Date:
- 2014-03-04
- Accepted Time:
- 2014-03-04 16:44:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1483825 | Fitterer Jean Lance | One Boston Scientific Place Natick MA 01760-1537 | Svp & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-28 | 4,190 | $0.00 | 121,667 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-28 | 3,382 | $0.00 | 125,049 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-28 | 2,545 | $13.10 | 122,504 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-28 | 10,000 | $13.20 | 112,504 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Deferred Stock Units | Disposition | 2014-02-28 | 3,382 | $0.00 | 3,382 | $0.00 |
| Common Stock | Deferred Stock Units | Disposition | 2014-02-28 | 4,190 | $0.00 | 4,190 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 46,614 | No | 4 | M | Direct | ||
| 42,424 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,661 | Indirect | By 401(k) |
Footnotes
- Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.190 to $13.201, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.
- Reflects multiple DSU awards with independent vesting schedules.
- Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
Billionaire Hedge Funds
